Haleon (NYSE:HLN) Rating Increased to Buy at Wall Street Zen

Haleon (NYSE:HLN) was upgraded by investment analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a report issued on Sunday.

Several other brokerages also recently weighed in on HLN. Rothschild & Co Redburn downgraded Haleon from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, June 16th. Weiss Ratings reissued a “hold (c)” rating on shares of Haleon in a report on Tuesday, June 30th. Argus upgraded shares of Haleon to a “strong-buy” rating in a research note on Tuesday, March 17th. Finally, Deutsche Bank Aktiengesellschaft reaffirmed a “sell” rating on shares of Haleon in a report on Thursday, April 30th. Two research analysts have rated the stock with a Strong Buy rating, three have given a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy”.

Haleon Stock Performance

HLN stock traded up $0.06 on Friday, reaching $9.77. The company’s stock had a trading volume of 3,940,688 shares, compared to its average volume of 8,904,478. Haleon has a 52 week low of $8.65 and a 52 week high of $11.28. The company has a market capitalization of $43.04 billion, a P/E ratio of 25.04, a price-to-earnings-growth ratio of 2.26 and a beta of 0.13. The firm has a fifty day moving average of $9.20 and a two-hundred day moving average of $9.86. The company has a debt-to-equity ratio of 0.47, a current ratio of 0.92 and a quick ratio of 0.71.

Institutional Investors Weigh In On Haleon

A number of institutional investors have recently added to or reduced their stakes in the company. IHT Wealth Management LLC raised its holdings in shares of Haleon by 6.9% in the fourth quarter. IHT Wealth Management LLC now owns 16,205 shares of the company’s stock valued at $164,000 after buying an additional 1,049 shares during the last quarter. National Bank of Canada FI grew its holdings in Haleon by 6.7% during the 3rd quarter. National Bank of Canada FI now owns 17,385 shares of the company’s stock worth $156,000 after acquiring an additional 1,099 shares during the last quarter. Oppenheimer & Co. Inc. increased its position in Haleon by 4.7% in the 4th quarter. Oppenheimer & Co. Inc. now owns 24,744 shares of the company’s stock valued at $250,000 after acquiring an additional 1,100 shares in the last quarter. Cary Street Partners Financial LLC increased its position in Haleon by 20.1% in the 2nd quarter. Cary Street Partners Financial LLC now owns 6,646 shares of the company’s stock valued at $69,000 after acquiring an additional 1,113 shares in the last quarter. Finally, Advisory Services Network LLC raised its stake in shares of Haleon by 7.1% in the third quarter. Advisory Services Network LLC now owns 17,431 shares of the company’s stock worth $156,000 after acquiring an additional 1,155 shares during the last quarter. 6.67% of the stock is currently owned by institutional investors and hedge funds.

About Haleon

Haleon plc (NYSE:HLN) is a global consumer healthcare company formed through the separation of a large pharmaceutical group’s consumer health business in 2022. Headquartered in the United Kingdom, Haleon develops, manufactures and markets a broad portfolio of over?the?counter medicines, oral health products, vitamins, minerals and supplements, and other consumer health goods designed for daily self?care and symptom relief.

The company’s product mix spans categories such as oral care (toothpastes and sensitivity treatments), pain relief and analgesics, respiratory remedies, digestive health products, topical treatments and nutritional supplements.